CRF Health: Romania investment part of growth strategy

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Bigandt_Photography)
(Image: iStock/Bigandt_Photography)

Related tags: Crf health, Clinical trial

CRF Health is investing in a new office location and workforce in Romania as it continues to expand its product and service portfolio.

The lași-based facility will support CRF Health’s existing sites at locations across the US, UK, and Finland, and is expected to open in the first quarter of 2017.

According to the company, the new site will be an integrated part of the business and include research and development for CRF Health’s product lines, and expanded customer service capabilities. 

“The decision to move to Romania was taken to help support our ambitious growth and expansion strategy, this being a key factor which enables the business to move forward at a much faster pace,” ​Sarah Dixon, Chief People Officer, CRF Health, told us.

‘It is an exciting time for technological innovation and CRF Health has been expanding our product and service portfolio to meet the needs of our evolving industry,” ​she added.

Over the last year, CRF Health launched its eConsent product, TrialConsent™ and acquired​ Entra Health – bolstering the company’s connectivity and establishing “a complete network of solutions to collect, manage and analyze biometric and clinical trial data,​” Dixon explained.

The company has engaged its preferred partners and is currently setting up the legal entity. It has also begun recruiting for roles across clinical trial and healthcare technology R&D, software design, operations, and project management.

Additionally, we are designing a global, new-hire orientation programme that will allow Romanian recruits to undertake training and induction abroad​,” said Dixon.

Opportunities are expected to “significantly increase​” by the end of 2017, according to the company.

Related news

Show more

Related products

show more

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Related suppliers

Follow us


View more